Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations-Reference-Cited by-同舟云学术

Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

Published:2019-10-14 Issue:12 Volume:73 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Gonzalez‐Barcala Francisco‐Javier¹²³⁴^ORCID,San‐Jose Maria‐Esther⁵,Nieto‐Fontarigo Juan‐José⁶,Calvo‐Alvarez Uxio⁷,Carreira Jose‐Martín⁸,Garcia‐Sanz Maria‐Teresa⁹,Muñoz Xavier²¹⁰,Perez‐Lopez‐Corona Maria-Purificacion³,Gómez‐Conde Maria-Jose⁵,Casas‐Fernández Alejandro⁵,Valdes‐Cuadrado Luis¹³⁴,Mateo‐Mosquera Lara³,Salgado Francisco‐Javier⁶

Affiliation:

1. Department of Medicine University of Santiago de Compostela Santiago Spain

2. Spanish Biomedical Research Networking Centre CIBERES Madrid Spain

3. Department of Respiratory Medicine University Hospital of Santiago de Compostela Santiago Spain

4. Health Research Institute of Santiago de Compostela (IDIS) Santiago Spain

5. Clinical Analysis Service University Hospital of Santiago de Compostela (CHUS) Santiago Spain

6. Faculty of Biology‐Biological Research Centre (CIBUS) Department of Biochemistry and Molecular Biology Universidade de Santiago de Compostela Santiago Spain

7. Department of Respiratory Medicine University Hospital of El Ferrol Santiago Spain

8. Department of Radiology University of Santiago de Compostela Santiago Spain

9. Emergency Department Hospital O Salnes Pontevedra Spain

10. Department of Respiratory Medicine Hospital Vall d'Hebron Barcelona Spain

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13423

Reference40 articles.

1. Global Strategy for the Diagnosis Management and Prevention of COPD Global Initiative for Chronic Obstructive Lung Disease (GOLD).2017.http://goldcopd.org. Accessed July 10 2019.

2. Is COPD Control a Useful Concept? Assessing Treatment Success by Evaluating COPD-Related Health Status

3. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable

4. Clasificación de los pacientes con enfermedad pulmonar obstructiva crónica según los sistemas de estadificación de la Asociación Latinoamericana de Tórax (ALAT) y la iniciativa global para la enfermedad pulmonar obstructiva crónica (GOLD)

5. Atención médica según el nivel de riesgo y su adecuación a las recomendaciones de la guía española de la enfermedad pulmonar obstructiva crónica (EPOC) (GesEPOC): Estudio EPOCONSUL

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarker defined infective and inflammatory asthma exacerbation phenotypes in hospitalized adults: clinical impact and phenotype stability at recurrent exacerbation;Journal of Asthma;2024-08-22

2. The association between blood eosinophils and clinical outcome of acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis;Respiratory Medicine;2024-02

3. Blood Eosinophil Count as a Predictive Biomarker of Chronic Obstructive Pulmonary Disease Exacerbation in a Real-World Setting;Canadian Respiratory Journal;2023-05-25

4. Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study;Toxics;2022-11-06

5. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study;Respiratory Research;2021-11-24